AgeX Therapeutics, Inc. (AGE)

Cash & Equivalents

$23.02M

Quarterly · Period ending: · USD

AGE logo

AGE Cash & Equivalents

Latest reported$3.06M
AGE FY Cash & Equivalents ($7.38M → $3.06M)
High-resolution chart · PNG

AGE cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
3,056,000
3,672,000
345,000
645,000
584,000
527,000
2,352,000
6,707,000
7,375,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.